SU14813 maleate - CAS# 849643-15-8 Size:Solid 10 mg Smiles: CN1CCC[C@@H](C1)COC1=CC(=CC2CN(CCOC=21)C(=O)CC)C1=CC(OC)=C(C=C1)OC

Smiles: CN1CCC[C@@H](C1)COC1=CC(=CC2CN(CCOC=21)C(=O)CC)C1=CC(OC)=C(C=C1)OC

This selectivity profile

Sodium phenylbutyrate is also a histone deacetylase inhibitor and chemical chaperone

Cefoselis hydrochloride exhibits good activity against a wide range of Gram-positive and Gram-negative organisms

Formula: C20H13F3N4O2S

SU14813 maleate - CAS# 849643-15-8 Size:Solid 10 mg Smiles: CN1CCC[C@@H](C1)COC1=CC(=CC2CN(CCOC=21)C(=O)CC)C1=CC(OC)=C(C=C1)OCSU14813 is an oral, multitargeted tyrosine kinase inhibitor (TKI) targeting vascular endothelial growth factor receptors (VEGFR), platelet derived growth factor receptors (PDGFR), KIT, and fms like tyrosine kinase 3 (FLT 3) (1). SU14813 was developed as a next generation TKI agent following sunitinib (SU11248) designed to demonstrate optimized pharmacokinetic (PK) and tolerability profiles. SU14813 demonstrated broad and potent antitumor activity